series-b
Stage
1
Investors
About
immunotherapies based on its proprietary lymph node targeting technology
Explore Elicio Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.
immunotherapies based on its proprietary lymph node targeting technology
Funding rounds, investor list, and risk signals — unlock with a subscription.